{"id":"https://openalex.org/W2562913093","doi":"https://doi.org/10.1158/1538-7445.am2015-ddt01-03","title":"Abstract DDT01-03: Discovery and pre-clinical pharmacology of AZD9496: An oral, selective estrogen receptor down-regulator (SERD)","display_name":"Abstract DDT01-03: Discovery and pre-clinical pharmacology of AZD9496: An oral, selective estrogen receptor down-regulator (SERD)","publication_year":2015,"publication_date":"2015-08-01","ids":{"openalex":"https://openalex.org/W2562913093","doi":"https://doi.org/10.1158/1538-7445.am2015-ddt01-03","mag":"2562913093"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2015-ddt01-03","doi":"https://doi.org/10.1158/1538-7445.am2015-ddt01-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-ddt01-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048485800","display_name":"Hazel M. Weir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hazel Weir","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053558300","display_name":"Mandy Lawson","orcid":"https://orcid.org/0009-0002-0781-8393","observed_orcids":["https://orcid.org/0009-0002-0781-8393"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mandy Lawson","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090206059","display_name":"Rowena J. Callis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rowena Callis","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091867223","display_name":"Michael Hulse","orcid":"https://orcid.org/0000-0002-6691-365X","observed_orcids":["https://orcid.org/0000-0002-6691-365X","https://orcid.org/0009-0000-7928-1842"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Hulse","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035608329","display_name":"Michael E. Tonge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Tonge","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101687947","display_name":"Gareth M. Davies","orcid":"https://orcid.org/0000-0002-3324-4154","observed_orcids":["https://orcid.org/0000-0002-3324-4154"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth Davies","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061486623","display_name":"Graeme E. Walker","orcid":"https://orcid.org/0000-0001-5344-9942","observed_orcids":["https://orcid.org/0000-0001-5344-9942"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graeme Walker","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032382796","display_name":"Rachel A. Rowlinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachel Rowlinson","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054135360","display_name":"Jon Curwen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jon Curwen","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069830252","display_name":"Zena Wilson","orcid":"https://orcid.org/0000-0001-8811-4069","observed_orcids":["https://orcid.org/0000-0001-8811-4069"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zena Wilson","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111144608","display_name":"Steve J. Powell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Steve Powell","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070422766","display_name":"Robert Hart Bradbury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Bradbury","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113674562","display_name":"Alfred A. Rabow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alfred Rabow","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064230058","display_name":"Craig S. Donald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Craig Donald","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008730613","display_name":"David Buttar","orcid":"https://orcid.org/0000-0001-5466-023X","observed_orcids":["https://orcid.org/0000-0001-5466-023X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Buttar","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084965826","display_name":"Richard A. Norman","orcid":"https://orcid.org/0000-0002-7764-3931","observed_orcids":["https://orcid.org/0000-0002-7764-3931"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Norman","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Camila de Almeida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Camila de Almeida","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089604553","display_name":"Peter G. Ballard","orcid":"https://orcid.org/0000-0003-2024-5219","observed_orcids":["https://orcid.org/0000-0003-2024-5219"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Ballard","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022871298","display_name":"Gordon S. Currie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gordon Currie","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066158171","display_name":"David William Andrews","orcid":"https://orcid.org/0000-0002-9266-7157","observed_orcids":["https://orcid.org/0000-0002-9266-7157"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Andrews","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070457926","display_name":"Graham H.P. Richmond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham Richmond","raw_affiliation_strings":["1AstraZeneca, Macclesfield, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Macclesfield, United Kingdom;","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037482943","display_name":"Anne Marie Mazzola","orcid":"https://orcid.org/0000-0003-3300-0245","observed_orcids":["https://orcid.org/0000-0003-3300-0245"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Marie Mazzola","raw_affiliation_strings":["2AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087701371","display_name":"Ermira Pazolli","orcid":"https://orcid.org/0009-0003-6219-2204","observed_orcids":["https://orcid.org/0009-0003-6219-2204"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ermira Pazolli","raw_affiliation_strings":["2AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003746155","display_name":"Brendon Ladd","orcid":"https://orcid.org/0009-0007-4322-0360","observed_orcids":["https://orcid.org/0009-0007-4322-0360"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brendon Ladd","raw_affiliation_strings":["2AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045990460","display_name":"Celina M. D\u2019Cruz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Celina D'Cruz","raw_affiliation_strings":["2AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030807494","display_name":"Chris De Savi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris De Savi","raw_affiliation_strings":["2AstraZeneca, Waltham, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Waltham, MA","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"15_Supplement","first_page":"DDT01","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.8804000020027161,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.8804000020027161,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.11029999703168869,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/estrogen-receptor-alpha","display_name":"estrogen receptor alpha","score":0.9190000295639038},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6349999904632568},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.7889999747276306},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.7680000066757202},{"id":"https://openalex.org/keywords/long-term-estrogen-deprivation","display_name":"long-term estrogen deprivation","score":0.7059999704360962},{"id":"https://openalex.org/keywords/progesterone-receptor","display_name":"progesterone receptor","score":0.7210000157356262},{"id":"https://openalex.org/keywords/receptor-degradation","display_name":"receptor degradation","score":0.5879999995231628},{"id":"https://openalex.org/keywords/mcf-7-xenografts","display_name":"MCF-7 xenografts","score":0.8140000104904175},{"id":"https://openalex.org/keywords/antihormonal-therapy","display_name":"antihormonal therapy","score":0.7979999780654907}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.9814140796661377},{"id":"https://openalex.org/C2776215463","wikidata":"https://www.wikidata.org/wiki/Q419143","display_name":"Anastrozole","level":5,"score":0.792123556137085},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.6933622360229492},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.689599871635437},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6120798587799072},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5643022656440735},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5283380746841431},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.4584171175956726},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.43028926849365234},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4013745188713074},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36758992075920105},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3608244061470032},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3244228959083557}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2015-ddt01-03","doi":"https://doi.org/10.1158/1538-7445.am2015-ddt01-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-ddt01-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2259828206","https://openalex.org/W2900845770","https://openalex.org/W3013714472","https://openalex.org/W3027962980","https://openalex.org/W2903742607","https://openalex.org/W3083736885","https://openalex.org/W2946165737","https://openalex.org/W2592929918","https://openalex.org/W2332737325","https://openalex.org/W3083183070"],"abstract_inverted_index":{"Abstract":[0],"With":[1],"over":[2],"70%":[3],"of":[4,31,48,57,73,131,149,172,218,244,266,333,342,420,432,437],"breast":[5,76,232,344],"cancers":[6],"expressing":[7],"estrogen":[8,32,60,286,425],"receptor":[9,61,229,275,426],"alpha":[10],"protein":[11,151,304,321],"(ER\u03b1),":[12],"treatment":[13,72,341],"with":[14,120,299],"either":[15],"anti-hormonal":[16],"therapies":[17,26],"that":[18,27,165,196,223],"directly":[19],"block":[20,28],"ER\u03b1":[21,50,85,150,181,226,303,319],"function":[22],"(e.g.":[23,34],"tamoxifen)":[24],"or":[25],"the":[29,43,46,49,54,58,71,80,113,129,147,157,213,245,293,340,347,433,438],"production":[30],"itself":[33],"anastrozole)":[35],"have":[36,189],"proven":[37],"to":[38,87,161,251],"be":[39,88,198],"effective":[40],"treatments":[41],"for":[42,339,441],"disease.":[44],"Following":[45],"discovery":[47,214],"antagonist":[51,314],"tamoxifen":[52],"in":[53,70,79,112,122,152,180,231,247,256,272,282,289,302,323,326,353],"1960s,":[55],"identification":[56],"selective":[59,424],"down-regulator":[62,427],"(SERD)":[63],"fulvestrant":[64,103,119],"represented":[65],"a":[66,91,191,220,264,283,336,354],"further":[67,178],"step":[68],"forward":[69],"advanced":[74,125],"ER+":[75],"cancer,":[77],"especially":[78],"endocrine":[81,137,258],"resistance":[82],"setting":[83],"where":[84,128],"appears":[86],"activated":[89],"by":[90],"ligand":[92],"independent":[93],"route":[94],"through":[95],"other":[96],"growth":[97,254],"factor":[98],"signaling":[99],"pathways.":[100],"In":[101],"addition,":[102],"has":[104],"also":[105,312],"shown":[106],"significant":[107,252,300],"overall":[108],"survival":[109],"(OS)":[110],"results":[111],"FIRST":[114],"trial":[115],"comparing":[116],"500":[117],"mg":[118],"anastrozole":[121],"first":[123],"line":[124],"ER+ve":[126,343],"patients":[127,132],"majority":[130],"had":[133],"not":[134],"received":[135],"prior":[136],"therapy.":[138],"Given":[139],"fulvestrant's":[140],"low":[141],"bioavailability":[142],"following":[143],"intramuscular":[144],"injection":[145],"and":[146,176,201,206,215,227,269,297,315,325,346,417],"levels":[148,171,182],"clinical":[153,186,207,337,357],"samples":[154],"after":[155],"treatment,":[156],"question":[158],"remains":[159],"as":[160,335],"whether":[162],"an":[163,257],"agent":[164],"could":[166,202],"achieve":[167],"higher":[168],"steady":[169],"state":[170],"drug":[173,348],"more":[174],"rapidly":[175],"drive":[177],"decreases":[179],"would":[183],"give":[184],"enhanced":[185],"benefit.":[187,208],"We":[188],"identified":[190],"novel,":[192],"potent,":[193],"non-steroidal":[194],"SERD":[195],"can":[197,224],"administered":[199],"orally":[200],"yield":[203],"improved":[204],"exposure":[205],"This":[209],"presentation":[210],"will":[211],"describe":[212],"pre-clinical":[216,248,418],"pharmacology":[217,419],"AZD9496,":[219],"small":[221],"molecule":[222],"antagonise":[225],"induce":[228],"degradation":[230],"cancer":[233,345],"cell":[234],"lines":[235],"at":[236,263,307],"picomolar":[237],"concentrations.":[238],"The":[239],"good":[240],"oral":[241],"pharmacokinetic":[242],"properties":[243],"compound":[246],"species":[249],"led":[250],"tumor":[253],"inhibition":[255],"sensitive":[259],"MCF-7":[260],"xenograft":[261],"model":[262],"dose":[265],"5":[267,308],"mg/kg":[268,309],">90%":[270,306],"reduction":[271],"ER-regulated,":[273],"progesterone":[274],"(PR)":[276],"levels.":[277],"Tumor":[278],"regressions":[279],"were":[280],"seen":[281],"long":[284],"term":[285],"deprived":[287],"(LTED)":[288],"vivo":[290],"model,":[291],"representing":[292],"aromatase":[294],"resistant":[295],"setting,":[296],"corresponded":[298],"reductions":[301],"levels,":[305],"dose.":[310],"AZD9496":[311,334],"showed":[313],"down-regulation":[316],"activity":[317],"against":[318],"mutant":[320],"both":[322],"vitro":[324],"vivo.":[327],"These":[328],"findings":[329],"strongly":[330],"supported":[331],"selection":[332],"candidate":[338],"is":[349],"now":[350],"under":[351],"evaluation":[352],"Phase":[355],"1":[356],"trial.":[358],"Citation":[359],"Format:":[360],"Hazel":[361],"Weir,":[362],"Mandy":[363],"Lawson,":[364],"Rowena":[365],"Callis,":[366],"Michael":[367,369],"Hulse,":[368],"Tonge,":[370],"Gareth":[371],"Davies,":[372],"Graeme":[373],"Walker,":[374],"Rachel":[375],"Rowlinson,":[376],"Jon":[377],"Curwen,":[378],"Zena":[379],"Wilson,":[380],"Steve":[381],"Powell,":[382],"Robert":[383],"Bradbury,":[384],"Alfred":[385],"Rabow,":[386],"Craig":[387],"Donald,":[388],"David":[389,400],"Buttar,":[390],"Richard":[391],"Norman,":[392],"Camila":[393],"de":[394],"Almeida,":[395],"Peter":[396],"Ballard,":[397],"Gordon":[398],"Currie,":[399],"Andrews,":[401],"Graham":[402],"Richmond,":[403],"Anne":[404],"Marie":[405],"Mazzola,":[406],"Ermira":[407],"Pazolli,":[408],"Brendon":[409],"Ladd,":[410],"Celina":[411],"D'Cruz,":[412],"Chris":[413],"De":[414],"Savi.":[415],"Discovery":[416],"AZD9496:":[421],"An":[422],"oral,":[423],"(SERD).":[428],"[abstract].":[429],"In:":[430],"Proceedings":[431],"106th":[434],"Annual":[435],"Meeting":[436],"American":[439],"Association":[440],"Cancer":[442,452],"Research;":[443],"2015":[444],"Apr":[445],"18-22;":[446],"Philadelphia,":[447],"PA.":[448],"Philadelphia":[449],"(PA):":[450],"AACR;":[451],"Res":[453],"2015;75(15":[454],"Suppl):Abstract":[455],"nr":[456],"DDT01-03.":[457],"doi:10.1158/1538-7445.AM2015-DDT01-03":[458]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2017-01-06T00:00:00"}